Samsung Biologics Co Ltd
KRX:207940
Samsung Biologics Co Ltd
Other Liabilities
Samsung Biologics Co Ltd
Other Liabilities Peer Comparison
Competitive Other Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Other Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Samsung Biologics Co Ltd
KRX:207940
|
Other Liabilities
₩417.5B
|
CAGR 3-Years
24%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
|
P
|
Peptron Inc
KOSDAQ:087010
|
Other Liabilities
₩3.6B
|
CAGR 3-Years
10%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
S
|
ST Pharm Co Ltd
KOSDAQ:237690
|
Other Liabilities
₩43B
|
CAGR 3-Years
105%
|
CAGR 5-Years
58%
|
CAGR 10-Years
N/A
|
F
|
FutureChem Co Ltd
KOSDAQ:220100
|
Other Liabilities
₩2.7B
|
CAGR 3-Years
5%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
L
|
LegoChem Biosciences Inc
KOSDAQ:141080
|
Other Liabilities
₩3.7B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
5%
|
C
|
Cellivery Therapeutics Inc
KOSDAQ:268600
|
Other Liabilities
₩587.6m
|
CAGR 3-Years
-27%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
See Also
What is Samsung Biologics Co Ltd's Other Liabilities?
Other Liabilities
417.5B
KRW
Based on the financial report for Mar 31, 2024, Samsung Biologics Co Ltd's Other Liabilities amounts to 417.5B KRW.
What is Samsung Biologics Co Ltd's Other Liabilities growth rate?
Other Liabilities CAGR 5Y
33%
Over the last year, the Other Liabilities growth was -58%. The average annual Other Liabilities growth rates for Samsung Biologics Co Ltd have been 24% over the past three years , 33% over the past five years .